The Prognostic Significance of Tumoral Melanosis
TM usually occurs in the context of a previous or subsequent cutaneous melanoma and is associated with improved MSS. It is important that TM is recognized by pathologists and documented in pathology reports.
Authors
- Alison J. Potter (ORCID: https://orcid.org/0000-0001-5493-6021)
- John F. Thompson (ORCID: https://orcid.org/0000-0002-2816-2496)
- Tasnia Ahmed (ORCID: https://orcid.org/0000-0001-7969-6335)
- Robert V. Rawson (ORCID: https://orcid.org/0000-0003-0655-4963)
- Serigne Lo (ORCID: https://orcid.org/0000-0001-5092-5544)
- Peter M. Ferguson (ORCID: https://orcid.org/0000-0002-8335-0406)
- Georgina Venetia Long (ORCID: https://orcid.org/0000-0001-8894-3545)
- Richard A. Scolyer (ORCID: https://orcid.org/0000-0002-8991-0013)
Institutions
- The University of Sydney (AU)
- New South Wales Department of Health (AU)
- Royal Prince Alfred Hospital (AU)
- Royal North Shore Hospital (AU)
- UNSW Sydney (AU)
- Melanoma Institute Australia (AU)
Publication Details
- Journal
- Journal of Cutaneous Pathology
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1111/cup.14727
- Citations
- 3
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Melanoma Institute Australia
- Medical Research Council
- National Health and Medical Research Council